Nick Navin

25PUBLICATIONS
223CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 18, 2026
Dual Functions of B7-H3-MAPK Signaling Orchestrate Tumor Immunosuppression via Regulating the Plasticity of Myeloid-derived Suppressor Cells and Fibroblasts.

|Jun 26, 2026
Tumor microbial burden drives immune responses through regulation of Interferon signaling.

|Jun 08, 2026
A pan-cancer single-cell analysis of intratumoral copy number diversity and evolution.

|May 13, 2026
Ecotypes of triple-negative breast cancer in response to chemotherapy.

|Apr 20, 2026
PRECISE: A Prognostic Thyrocyte-Derived Gene Signature for Papillary Thyroid Carcinoma.

|Jan 29, 2026
Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET).

Chibawanye I Ene, Sanjay Singh, Thiagarajan Venkataraman

Pageof 5

Frequent Collaborators

5 joint publications

Tapsi Kumar

5 joint publications

Ken Chen

4 joint publications

Bora Lim

3 joint publications

Yun Yan